The role of radiotherapy in HER2+ early-stage breast cancer patients after breast-conserving surgery

The role of radiotherapy in HER2+ early-stage breast cancer patients after breast-conserving surgery

BackgroundDue to radioresistance, some HER2+ patients may gain limited benefit from radiotherapy (RT) after breast-conserving surgery (BCS). This study aimed to develop an individualized nomogram to identify early-stage HER2+ patients who could omit RT after BCS.MethodsThe data of HER2+ patients wit...

Full description

Bibliographic Details
Main Authors: Huanzuo Yang, Mengxue Qiu, Yu Feng, Nan Wen, Jiao Zhou, Xiangquan Qin, Juan Li, Xinran Liu, Xiaodong Wang, Zhenggui Du
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
HER2+ breast cancer
breast-conserving surgery
radiotherapy
radioresistance
nomogram
SEER program
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.903001/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.903001/full

Similar Items